Qiagen, NL0012169213

Qiagen stock ends the day unchanged at the close on the NYSE

Published on 09/21/2026 at 23:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

On September 21, 2026, Qiagen stock closed at USD 43.37 on the NYSE, unchanged from its prior finish, while the broader S&P 500 advanced more than 1 percent. Investors now look ahead to corporate governance developments following Qiagen’s call for an extraordinary general meeting.

Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte, klinisches Laborlicht
Qiagen N.V. (NL0012169213) Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte im klinischen Labor, Illustration mit AI erstellt.

Qiagen stock closed at USD 43.37 on the New York Stock Exchange on September 21, 2026, leaving the share price broadly unchanged from its prior close in U.S. trading. Compared with the wider U.S. market, the stock lagged the S&P 500, which posted a gain of about 1 percent on the day.

September 21, 2026 in numbers

Qiagen N.V. (ISIN NL0012169213, NYSE: QGEN) traded in a relatively narrow range on September 21, 2026, with intraday moves around its USD 43 level on the NYSE. The price action left the stock roughly flat versus the previous U.S. close, while the S&P 500 finished the session higher by about 1 percent, underscoring the stock’s underperformance against the benchmark. Earlier in the week the shares had ended at USD 43.37 on September 18, 2026, down 2.27 percent, as reported by ad-hoc-news.de, so today’s flat close kept the stock near that level.

After the bell and the next session

After the close on September 21, 2026, attention turned to governance developments at the company. Qiagen announced an extraordinary general meeting to vote on the appointment of Jonathan M. Pratt to its Managing Board, according to a company release cited by BioSpace. This planned meeting is set to shape the company’s leadership structure and may influence sentiment toward Qiagen stock on the next U.S. trading day, September 22, 2026, when the shares resume trading on the NYSE.

Disclaimer...

en | NL0012169213 | QIAGEN | boerse | 70147580 | bgmi